Trademark: 85121610
Status Date
Monday, November 12, 2012
Filing Date
Thursday, September 2, 2010
Published for Opposition
Tuesday, February 15, 2011
Abandoned Date
Monday, November 12, 2012
5 pharmaceuticals for the treatment of inflammatory, autoimmune, cardiovascular, metabolic, oncological, dermatologic, neurologic, gastroenteric, and infectious diseases and conditions; monoclonal antibodies for medical purposes
Color is not claimed as a feature of the mark.
The mark consists of two curved lines starting from the same point.
Nov 13, 2012
Abandonment Notice Mailed - No Use Statement Filed
Nov 12, 2012
Abandonment - No Use Statement Filed
May 4, 2012
Notice Of Approval Of Extension Request Mailed
May 3, 2012
Extension 2 Granted
Apr 11, 2012
Extension 2 Filed
May 3, 2012
Case Assigned To Intent To Use Paralegal
Apr 11, 2012
Teas Extension Received
Oct 6, 2011
Notice Of Approval Of Extension Request Mailed
Oct 4, 2011
Extension 1 Granted
Oct 4, 2011
Extension 1 Filed
Oct 4, 2011
Teas Extension Received
Apr 12, 2011
Noa Mailed - Sou Required From Applicant
Feb 15, 2011
Published For Opposition
Jan 26, 2011
Notice Of Publication
Jan 10, 2011
Law Office Publication Review Completed
Jan 10, 2011
Assigned To Lie
Dec 15, 2010
Approved For Pub - Principal Register
Dec 15, 2010
Assigned To Examiner
Sep 8, 2010
Notice Of Design Search Code Mailed
Sep 7, 2010
New Application Office Supplied Data Entered In Tram
Sep 6, 2010
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
